Statins are generally not recommended while breastfeeding, but they are no longer strictly contraindicated for all women. In 2021, the FDA updated its statin labeling to allow for individualized decision-making, particularly for women at very high risk of heart attack or stroke. For most breastfeeding mothers, though, the standard advice is to pause statin therapy temporarily and resume after weaning.
What the FDA Currently Says
Until 2021, statins carried the FDA’s strongest warning against use during pregnancy. That blanket contraindication has been removed. The updated guidance tells healthcare providers to discuss whether a breastfeeding patient can stop their statin temporarily during the nursing period. For women who genuinely need a statin because of their cardiovascular risk, such as those with a history of heart attack, stroke, or a severe genetic cholesterol condition called homozygous familial hypercholesterolemia, the FDA advises against breastfeeding and recommends using infant formula instead.
The reasoning is straightforward: statins can pass into breast milk, and the long-term effects on a nursing infant aren’t well studied. Because high cholesterol is a chronic condition, pausing treatment for several months while breastfeeding is unlikely to cause a cardiovascular event in most women. The exception is the small group whose risk is high enough that stopping treatment, even briefly, could be dangerous.
Why Cholesterol Matters for Infant Development
The main concern with statin exposure during breastfeeding isn’t a specific known side effect. It’s the theoretical risk of disrupting an infant’s cholesterol production during a period when cholesterol is critically important for brain development.
Cholesterol is the dominant building block of myelin, the insulating sheath that wraps around nerve fibers and allows the brain to transmit signals efficiently. About 70% of the brain’s cholesterol is stored in myelin, and cholesterol makes up roughly 40% of myelin’s total fat content, more than any other single lipid. During infancy, the brain synthesizes and accumulates cholesterol at its highest rate to keep up with rapid growth, myelination, and the formation of new neural connections. Cholesterol also plays a direct role in how neurons branch out, form synapses, and mature.
Statins work by blocking the enzyme that controls the first step of cholesterol production. In lab studies, inhibiting cholesterol synthesis in developing nerve cells interfered with the branching of dendrites (the parts of neurons that receive signals) and reduced the maturation of the cells responsible for producing myelin. Whether the tiny amount of statin that reaches an infant through breast milk could meaningfully affect these processes is unknown, but the concern is enough to drive the cautious approach.
How Much Statin Actually Reaches Breast Milk
Not all statins behave the same way. Some are lipophilic, meaning they dissolve easily in fats and are more likely to cross into breast milk. Others are hydrophilic, meaning they dissolve in water and theoretically transfer into milk at lower levels. Pravastatin and rosuvastatin are both hydrophilic, which is why they come up most often in discussions about breastfeeding safety.
In one case study that directly measured pravastatin in breast milk, the drug was undetectable in milk samples taken three days after the last dose. Statins also tend to have low oral bioavailability, meaning that even if small amounts reach the milk, a relatively small fraction would be absorbed through the infant’s gut. No adverse effects have been reported in breastfed infants whose mothers were taking statins. Some experts have pointed out that children with severe genetic cholesterol disorders are treated with statins starting as young as one year of age, which suggests the drugs may not pose a serious risk at the low levels found in breast milk.
Still, “no reported side effects” is not the same as “proven safe.” The number of breastfeeding women studied while taking statins is very small, and no long-term follow-up data exists on exposed infants.
If You and Your Doctor Decide to Continue
For women who do take a statin while breastfeeding, whether by individual clinical decision or because they didn’t realize they should stop, the UK’s NHS Specialist Pharmacy Service recommends monitoring the infant as a precaution. This means watching that the baby is feeding well, gaining weight as expected, and not showing signs of digestive upset, unusual drowsiness, or irritability. These apply regardless of which statin is being used.
If a statin is continued, pravastatin or rosuvastatin are generally considered the lowest-risk options due to their water-soluble properties and lower expected transfer into breast milk.
Alternatives During Breastfeeding
For most women, the simplest approach is to pause statin therapy for the duration of breastfeeding. Cholesterol treatment is a long game, and a break of several months to a year is unlikely to change your cardiovascular trajectory in a meaningful way.
Bile acid sequestrants are one class of cholesterol-lowering medication that can be used during both pregnancy and breastfeeding. These drugs work inside the gut and are not absorbed into the bloodstream, so they don’t reach breast milk. They’re less potent than statins and can raise triglyceride levels, but they’re the only lipid-lowering option considered clearly compatible with nursing.
Lifestyle measures, including dietary changes and physical activity, can also help manage cholesterol during this period. For most women, these strategies combined with a temporary medication pause are enough to bridge the gap until breastfeeding ends and full statin therapy can resume.
The High-Risk Exception
A small number of women face a genuinely difficult trade-off. Those with homozygous familial hypercholesterolemia, a genetic condition that can push LDL cholesterol to extreme levels, or those with a recent history of heart attack or stroke may not be able to safely stop their statin for months. For these women, the FDA’s position is clear: if you need the statin, use formula instead of breastfeeding. In some cases, a procedure called lipoprotein apheresis, which physically filters cholesterol from the blood, can be used as a non-drug alternative to maintain cholesterol control without exposing the infant to medication through breast milk.